All Stories

  1. Development and validation of reversed phase–high-performance liquid chromatography method for simultaneous quantification of temozolomide and alpha-lipoic acid in bulk and lipidic nanovesicles
  2. Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation
  3. Integrated stability and metabolomic investigation of new Rifampicin and Isoniazid co-loaded liposome against tuberculosis
  4. A review on intervention of AI in pharmaceutical sector: Revolutionizing drug discovery and manufacturing
  5. Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer
  6. Pharmaceutical medicine advertising regulations in Australia, Japan, the United States, and India: An overview
  7. Biowaiver based on biopharmaceutics classification system: Considerations and requirements
  8. Interactions between multifunctional pharmaceutical excipients and efflux pump for optimal drug transport and bioavailability: An overview
  9. Biopharmaceutical advancement of efonidipine hydrochloride ethanolate through amorphous solid dispersion of a Parteck SLC mesoporous silica polymer
  10. Artificial intelligence in pharmaceutical regulatory affairs
  11. Common chemistry, manufacturing, and control deficiencies in abbreviated new drug applications assessed by the US Food and drug administration: Hurdle to access cost-effective medicines
  12. Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: In-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit
  13. Evaluation of curcumin-loaded chitosan nanoparticles for wound healing activity
  14. Bioanalytical method development and Validation for determination of efonidipine hydrochloride ethanolate in rat plasma by high-performance liquid chromatography: applications for pharmacokinetic study
  15. Microwave-assisted grafting of acrylamide on a natural xylan gum for controlled drug delivery
  16. Investigation of a Quantitative Bioanalytical HPLC Method for the Assessment of Famotidine in Pre-clinical Samples: Application for Pharmacokinetic Studies
  17. Artificial intelligence (AI) in drug product designing, development, and manufacturing
  18. Synthesis and characterization of chitosan nanoparticles decorated with folate and loaded with dasatinib for targeting folate receptors in cancer cells
  19. Interactive Teaching in Higher Education for Effective Knowledge Dissemination and Improved Student Participation
  20. Effect of polymers and process parameters in augmenting the compactability and dissolution behaviour of oxcarbazepine spherical agglomerates
  21. COMPARATIVE PHARMACEUTICAL EVALUATION OF VARIABLE RETAIL PRICED MEDICINES CONTAINING BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS-II OR CLASS-IV DRUGS
  22. International Regulations for Bioequivalence Approval of Locally Acting Orally Inhaled Drug Products
  23. Development of lipoprotein-drug conjugates for targeted drug delivery
  24. Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
  25. An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia
  26. Global Pediatric Regulations: An Overview
  27. QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl Methylcellulose (Cellulose Ethers) Tablets Based on Its Degree of Polymerization
  28. Global Pediatric Regulations: An Overview
  29. Quantitative Structure–Property Relationship Approach in Formulation Development: an Overview
  30. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design
  31. Bioanalytical method development and validation for estimation of formulated sustained release tablet of Nateglinide in Rabbit plasma.
  32. An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia
  33. Characterization of pharmaceutical nanocarriers: in vitro and in vivo studies
  34. Development of Stability-Indicating HPLC Method and Accelerated Stability Studies for Osmotic and Pulsatile Tablet Formulations of Clopidogrel Bisulfate
  35. Development of controlled release cellulose-pellets based multicore tablets
  36. Quantitative structure–property relationship modeling for the prediction of hydrophilic drug entrapment in liposomes for lung targeted delivery
  37. Computational Modeling of Polymeric Physicochemical Properties for Formulation Development of a Drug Containing Basic Functionality
  38. Design and development of potent and selective factor IXa inhibitors
  39. Statistical significance of polymeric physicochemical properties in the development of formulations containing a drug from neutral class
  40. Quantitative structure property relationship modeling of excipient properties for prediction of formulation characteristics
  41. Experimental and chemoinformatics evaluation of some physicochemical properties of excipients influencing release kinetics of the acidic drug ibuprofen
  42. Polymers influencing transportability profile of drug
  43. Investigation of tablettability and drug release properties of ethyl cellulose
  44. Glass transition temperature: Basics and application in pharmaceutical sector